Paradigm Biocapital Advisors LP

Position in RVMD — Revolution Medicines, Inc.

CIK 1855655 NEW YORK, NY

Position in RVMD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,191,348,571

+$544,081,455 QoQ

Shares Held

6,361,323

-4.4% QoQ

Ownership

2.97%

of shares outstanding

% of Portfolio

25.85%

of 13F equity value

Holder Rank

#10

of 687 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Paradigm Biocapital Advisors LP holds $4,608,890,546 across 28 Biotechnology names. RVMD ranks #1 (25.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc. This page	6,361,323	$1,191,348,571
2	EWTX	Edgewise Therapeutics, Inc.	10,215,455	$415,053,936
3	GMAB	Genmab A/S	13,133,131	$360,767,108
4	SYRE	Spyre Therapeutics, Inc.	3,840,778	$340,984,270
5	APGE	Apogee Therapeutics, Inc.	1,576,385	$209,233,581
6	ORKA	Oruka Therapeutics, Inc.	2,144,526	$204,094,539
7	TNGX	Tango Therapeutics, Inc.	6,357,523	$198,736,168
8	BLTE	Belite Bio, Inc	1,232,877	$189,844,564

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,191,348,571	6,361,323	-4.4%	Shares	Sole	2026-08-14
2026-03-31	$647,267,116	6,655,703	+0.2%	Shares	Sole	2026-05-15
2025-12-31	$529,226,698	6,644,403	+6.8%	Shares	Sole	2026-02-17
2025-09-30	$290,627,689	6,223,291	+2.1%	Shares	Sole	2025-11-14
2025-06-30	$224,172,175	6,093,291	-1.4%	Shares	Sole	2025-08-14
2025-03-31	$218,458,004	6,178,111	-5.7%	Shares	Sole	2025-05-15
2024-12-31	$286,633,075	6,553,111	+23.3%	Shares	Sole	2025-02-14
2024-09-30	$240,993,936	5,314,089	+1.0%	Shares	Sole	2024-11-14
2024-06-30	$204,105,244	5,259,089	+80.4%	Shares	Sole	2024-08-14
2024-03-31	$93,949,644	2,914,975	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.